Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 07 02:01PM ET
2.12
Dollar change
+0.06
Percentage change
2.91
%
Index- P/E- EPS (ttm)-0.25 Insider Own5.70% Shs Outstand66.77M Perf Week-5.78%
Market Cap141.55M Forward P/E- EPS next Y-0.30 Insider Trans0.00% Shs Float62.96M Perf Month23.98%
Income-12.11M PEG- EPS next Q-0.09 Inst Own34.31% Short Float / Ratio3.05% / 6.31 Perf Quarter41.33%
Sales48.06M P/S2.95 EPS this Y88.84% Inst Trans-4.22% Short Interest1.92M Perf Half Y-1.40%
Book/sh-1.54 P/B- EPS next Y-138.67% ROA-21.76% Target Price6.33 Perf Year135.50%
Cash/sh0.37 P/C5.68 EPS next 5Y- ROE- 52W Range0.72 - 2.69 Perf YTD135.01%
Dividend- P/FCF23.59 EPS past 5Y-19.73% ROI-1868.98% 52W High-21.19% Beta2.72
Dividend %- Quick Ratio1.47 Sales past 5Y-5.88% Gross Margin55.19% 52W Low194.44% ATR0.18
Employees130 Current Ratio1.76 Sales Q/Q13.43% Oper. Margin-45.58% RSI (14)56.56 Volatility12.88% 8.87%
OptionableYes Debt/Eq- EPS Q/Q86.57% Profit Margin-25.20% Rel Volume1.33 Prev Close2.06
ShortableYes LT Debt/Eq- EarningsNov 06 AMC Payout- Avg Volume304.25K Price2.12
Recom1.00 SMA208.44% SMA5026.36% SMA20031.20% Volume286,370 Change2.91%
Date Action Analyst Rating Change Price Target Change
Apr-07-21Resumed RBC Capital Mkts Outperform $7
Apr-22-19Initiated H.C. Wainwright Buy
Jan-03-19Initiated Lake Street Buy $14
Aug-20-18Initiated RBC Capital Mkts Outperform $23
Aug-20-18Initiated JMP Securities Mkt Outperform $29
Dec-05-23 08:00AM
Nov-29-23 09:55AM
Nov-27-23 12:00PM
09:40AM
Nov-16-23 12:00PM
09:40AM Loading…
Nov-10-23 09:40AM
08:00AM
Nov-08-23 02:58PM
Nov-06-23 05:55PM
05:54PM
04:37PM
Nov-02-23 08:00AM
Nov-01-23 06:00PM
Oct-31-23 08:00AM
Oct-24-23 06:00PM
06:15PM Loading…
Oct-09-23 06:15PM
08:00AM
Oct-03-23 06:15PM
Sep-27-23 06:15PM
Sep-21-23 12:24PM
Sep-20-23 09:04AM
Sep-15-23 06:00PM
Sep-13-23 06:15PM
Sep-12-23 08:26AM
Sep-11-23 08:00AM
Aug-23-23 08:00AM
Aug-11-23 07:08AM
Aug-10-23 10:03AM
Aug-07-23 05:40PM
04:38PM
04:01PM Loading…
04:01PM
Aug-02-23 08:00AM
Jul-27-23 07:00AM
Jul-25-23 04:01PM
08:00AM
Jul-21-23 06:00PM
Jul-18-23 06:15PM
Jul-14-23 09:40AM
Jul-12-23 06:15PM
Jul-06-23 08:00AM
Jun-29-23 09:35AM
08:42AM
Jun-28-23 09:40AM
Jun-20-23 07:14PM
Jun-14-23 08:00AM
Jun-12-23 09:40AM
May-31-23 08:00AM
May-26-23 09:40AM
May-11-23 12:00PM
May-09-23 10:00AM
May-04-23 06:17AM
May-02-23 06:15PM
05:13PM
04:31PM
Apr-26-23 10:02AM
08:00AM
Apr-25-23 10:01AM
Apr-20-23 08:00AM
Apr-18-23 08:00AM
Apr-17-23 07:18AM
Mar-29-23 08:30AM
Mar-08-23 11:43PM
Mar-07-23 05:15PM
04:01PM
Mar-01-23 10:00AM
08:00AM
Feb-28-23 10:00AM
Feb-22-23 08:00AM
Feb-21-23 08:00AM
Feb-13-23 10:31AM
Jan-27-23 05:51AM
Jan-06-23 08:00AM
Dec-22-22 08:00AM
Nov-29-22 08:00AM
Nov-15-22 08:00AM
Nov-09-22 04:33PM
Nov-01-22 05:15PM
04:01PM
Oct-27-22 09:05AM
09:00AM
Oct-24-22 08:00AM
Oct-19-22 08:00AM
Oct-11-22 08:00AM
Sep-28-22 12:14PM
08:00AM
Sep-27-22 09:35AM
07:00AM
Sep-12-22 04:01PM
Aug-31-22 04:02PM
08:00AM
Aug-10-22 04:50PM
Aug-04-22 12:34PM
09:56AM
12:30AM
Aug-02-22 05:15PM
04:02PM
Jul-26-22 08:00AM
Jul-20-22 08:00AM
Jul-11-22 08:00AM
Jun-16-22 07:32AM
Aquestive Therapeutics, Inc. engages in the identifying, developing, and commercializing differentiated products to address unmet medical needs and to solve patients' therapeutic problems. Its product pipeline include Libervant, AQST-108, AQST-305, Suboxone and Zuplenz. The company was founded in January 2004 and is headquartered in Warren, NJ.